Risk Assessment and Primary VTE Prevention in the Cancer Patient

Publisher： Karger

E-ISSN： 1424-8840|33|1|36-41

ISSN： 1424-8832

Source： Pathophysiology of Haemostasis and Thrombosis, Vol.33, Iss.1, 2003-09, pp. : 36-41

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Adverse drug reactions (ADRs): a patient perspective on assessment and prevention in primary care

By Kieve Millie  

Quality in Primary Care, Vol. 15, Iss. 4, 2007-08 ,pp. : 221-228

Radcliffe Press

Access to resources Recommend Favorite

Treatment and Secondary Prophylaxis of VTE in the Cancer Patient: Current Status

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 33, Iss. 1, 2003-09 ,pp. : 42-43

Karger

Access to resources Recommend Favorite

Effects of a global risk educational tool on primary coronary prevention: the Atherosclerosis Assessment Via Total Risk (AVIATOR) study

By Jacobson Terry A.   Gutkin Stephen W.   Harper Charles R.  

Current Medical Research and Opinion, Vol. 22, Iss. 6, 2006-06 ,pp. : 1065-1073

Informa Healthcare

Access to resources Recommend Favorite

Cardio-metabolic risk prediction should be superior to cardiovascular risk assessment in primary prevention of cardiovascular diseases

By Rosolova Hana  

The EPMA Journal, Vol. 2, Iss. 1, 2011-03 ,pp. : 15-26

Springer Publishing Company

Access to resources Recommend Favorite

Risk Factors for Thrombosis and Bleedings Prevention of Arterial and Venous Thrombosis Treatment of VTE and Adverse Reactions

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 29, Iss. 1, 2004-11 ,pp. : 121-127

Karger

Access to resources Recommend Favorite